Clinical trials
Death clinical trials
Below are recruiting death clinical trials, each written for real people, not researchers. We’re tracking 146 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06768515Recruiting
Organ donation from brain-dead ICU patients
This study looks at how brain-dead patients are cared for in the ICU before organ donation to see if certain practices help with getting more usable organs. It may help improve the donation process for future patients.
ParisAges 18 years+ - NCT06764225Recruiting
Low-Sodium Salt for Heart Failure Patients
This study tests whether using a low-sodium salt substitute can help people with heart failure live longer, avoid hospital visits, and feel better. It's for adults with a weakened heart pump who have a caregiver and eat home-cooked meals.
Beijing, Beijing MunicipalityAges 18–75 - NCT07028372Recruiting
Long-term follow-up of cardiac arrest survivors who had ultra-rapid cooling
This trial checks on the long-term health of people who survived a cardiac arrest and received ultra-rapid cooling as part of an earlier study (OverCool). The goal is to see how they are doing over time.
AngersAges 18 years+ - NCT07020702Recruiting
Predicting sudden cardiac death risk in heart muscle disease
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
Clermont-FerrandAges 18–80 - NCT07011940Recruiting
Walk with me for grief after pregnancy or infant loss
This study tests a program called Walk With Me to help people cope with grief after losing a pregnancy or a baby shortly after birth. It is for those who are in the first month after the loss, live in the US, and speak English or Spanish.
Eugene, OregonAges 15 years+ - NCT07009847Recruiting
Study of the R21/Matrix-M malaria vaccine
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
Bousse, Burkina FasoAges 5 months+ - NCT05651347RecruitingPhase 3
Melatonin in pregnancy to protect babies with slow growth
This trial studies whether taking melatonin during pregnancy can help protect the baby’s brain and organs in cases of poor fetal growth. It focuses on pregnancies at a specific gestational age with signs that the placenta may not be working well.
Camperdown, New South WalesAges 18 years+ - NCT06964464RecruitingPhase 4
Comparing two heart failure medications in ICD patients
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Scottsdale, ArizonaAges 18 years+ - NCT06771700Recruiting
S-ICD implantation study for heart patients
This study looks at implanting a type of ICD (implantable cardioverter-defibrillator) called a subcutaneous ICD, or S-ICD, which goes under the skin instead of in the heart. It is designed to help see how well this works in standard care.
Cologne, North Rhine-WestphaliaAges Any age - NCT06763549Enrolling by invitation
AI-powered wearable patch for heart and lung monitoring
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
Melbourne, FloridaAges 18 years+ - NCT06705751Recruiting
Faster diagnosis of abnormal coronary artery origin
This study tests a new, faster way to diagnose an uncommon heart condition where one of the main arteries (the coronary artery) starts from the wrong place on the aorta. The goal is to help doctors find and treat it sooner.
San Donato Milanese, ItaliaAges 6 years+ - NCT06677060RecruitingPhase 3
Study of baxdrostat plus dapagliflozin for heart risk in type 2 diabetes
This study tests whether a new drug called baxdrostat, when added to the diabetes medicine dapagliflozin (Farxiga), can prevent heart failure and heart-related death in people with type 2 diabetes, high blood pressure, and existing heart or blood vessel disease. You may be able to join if you have type 2 diabetes, heart or blood vessel disease, high blood pressure, and at least one extra risk factor for heart failure.
Birmingham, AlabamaAges 40 years+ - NCT06642168Recruiting
Genetic Testing for Sudden Cardiac Arrest in Young Athletes
This study looks at young people who had a sudden cardiac arrest during sports. Doctors will check for genetic causes to help prevent future events in athletes and their families.
Nîmes, FranceAges 12–35 - NCT06546137Recruiting
Registry for inherited heart conditions in Brazil
This study is building a national registry in Brazil to learn more about inherited heart conditions and improve care. If you have a family-related heart disease, you may be able to join and help advance cardiovascular healthcare.
Rio Branco, AcreAges Any age - NCT06464315Enrolling by invitation
VT Ablation Guided by Scar Tissue Only
This trial tests a new approach to treating a dangerous heart rhythm called ventricular tachycardia (VT) in people with scarred heart muscle. The goal is to use only the scarred area to guide the ablation procedure, which may make it safer and more effective.
San Diego, CaliforniaAges 18–90 - NCT06437132Enrolling by invitation
Digital Thanotyping for End-of-Life Care in Dementia
This study tests a digital system (called 'thanotyping') to better understand the last stages of life in people with dementia who live in nursing homes. The goal is to improve care and support for both patients and families during this time.
Bergen, VestlandAges 65 years+ - NCT06361303Recruiting
SNOO smart sleeper study for infant safety
This study is looking at how well the SNOO smart sleeper helps keep babies safe during sleep. If you have or plan to use a SNOO and your baby has certain risk factors, you may be able to join.
Los Angeles, CaliforniaAges 18 years+ - NCT06345729RecruitingPhase 3
Combination drug therapy for advanced lung cancer
This trial tests a new pill (calderasib) combined with an immunotherapy drug (pembrolizumab) for people with a specific type of advanced non-small cell lung cancer. It aims to see if the combination can shrink tumors or slow their growth.
Bakersfield, CaliforniaAges 18 years+ - NCT06310434Enrolling by invitation
Understanding compassion in teens and young adults facing end-of-life
This study looks at how teenagers and young adults understand compassion and human connection when facing the end of life. It may help improve how schools and families support young people during difficult times.
Murcia, MUAges 12–23 - NCT06308952RecruitingPhase 4
Atorvastatin before flow diverter for brain aneurysms
This trial tests whether taking atorvastatin before a flow diverter procedure can prevent strokes or other brain events in people with unruptured brain aneurysms. It may help reduce complications from the treatment.
Guangzhou, GuangdongAges 18–75 - NCT06292299Recruiting
Breathing monitor study for children with sleep or breathing issues
This study looks at how well a new breathing monitor works for children with sleep problems, breathing pauses in newborns, or epilepsy. It may help doctors better understand breathing patterns without extra needles or blood tests.
Glasgow, Glasgow CityAges 1 minute–16 years - NCT06279975Recruiting
Pupil test in patients being checked for brain death
This study uses a special camera to measure pupil reactions in patients being evaluated for brain death. The aim is to see if this test can help confirm the diagnosis of brain death more accurately.
Basel, Canton of Basel-CityAges 18 years+ - NCT06253000Recruiting
Heat vs. Freezing for the Back of the Heart
This trial tests two ways to treat the back wall of the heart's left chamber in people with stubborn atrial fibrillation. It compares radiofrequency (heat) and cryoablation (freezing) to see which is safer and works better.
MoscowAges 18–80 - NCT06240715Recruiting
Umbilical cord milking for premature babies who need help at birth
This study tests whether gently squeezing the umbilical cord before clamping it (called cord milking) helps premature babies who are not vigorous at birth. It is being done in hospitals with fewer resources to find safe and effective ways to improve oxygen and blood flow right after delivery.
Belagavi, KarnatakaAges birth–10 minutes
Hear when a new Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for death?
- Yes. Clin2 currently lists 146 recruiting death studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a death trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a death trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.